@xconomy.com 4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@Murph_CJ 7 years ago
RT @DrWeidner: AstraZeneca plans new connected inhaler trial to improve medication adherence in COPD patients | #digitalhealth http://mobihealthnews.com/content/astrazeneca-plans-new-connected-inhaler-trial-improve-medication-adherence-copd-patients